NorthWest Biotherapeutics Inc (NWBO)

[Know-Fear]

Thanks. In regards to combination trials I think most here including myself saw potential of CI with Direct due to tumor burden. I was somewhat surprised when Prins announced CI combo with L. And yes the trials with L will be a small university run study not a partnership in conjunction with BP as there is IMO a greater risk of an adverse side effect treating GBM with L/CI combo than treating solid tumors outside the cranium with a Direct/CI combo. That said they would be wise not to start the trials with L before trials with Direct are established lest any perceived mishap with L trials derail or delay Direct trials.